Orange Book product · Generic (ANDA)
MIDOSTAURIN
MIDOSTAURIN
Generic (ANDA)ANDA 216076DISCN TEVA PHARMS
At a glance
Apr 29, 2024
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 29, 2024
2 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
MIDOSTAURIN
Strength
25MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 216076
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MIDOSTAURIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
